Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2514]

Nanotechnology based blood test to predict aggressive prostate cancer accurately

Nanotechnology based blood test to predict aggressive prostate cancer accurately

Genetic mutations predict patient response to immunotherapy

Genetic mutations predict patient response to immunotherapy

New cellular imaging paves way for cancer treatment

New cellular imaging paves way for cancer treatment

Combined modality treatment could be first course of treatment for muscle-invasive bladder cancer

Combined modality treatment could be first course of treatment for muscle-invasive bladder cancer

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Abiraterone slows advanced prostate cancer, helps patients live longer in STAMPEDE trial

ASCO 2017: Abiraterone slows advanced prostate cancer, helps patients live longer in STAMPEDE trial

ASCO 2017: Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

ASCO 2017: Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

ASCO 2017: LATITUDE trial of abiraterone for metastatic prostate cancer doubles median PFS

ASCO 2017: LATITUDE trial of abiraterone for metastatic prostate cancer doubles median PFS

ASCO 2017: Low testosterone after testicular cancer is common, linked to chronic health problems

ASCO 2017: Low testosterone after testicular cancer is common, linked to chronic health problems

New plasmonic sensor improves early cancer detection

New plasmonic sensor improves early cancer detection

More from ecancer